Earnings Releases·Nov 5, 2026, 4:10 PM ET

Astrana Health, Inc. — Third Quarter 2026 Earnings Summary

Q3 2026 total revenue reached $1,023.6 million (up 7% YoY), while net income surged to $13.0 million from $0.4 million; Adjusted EBITDA rose 13% YoY to $77.2 million and Adjusted EPS increased 4% to $0.71.
Full-year 2026 guidance was narrowed to $3.90–$4.00 billion in revenue, $261–$274 million in Adjusted EBITDA, and $107.5–$130 million in free cash flow.
Strategic growth includes the October 1, 2026, acquisition of a Georgia independent practice association, new Medicare Advantage partnerships effective January 1, 2027, and two new Care Enablement clients onboarding in early 2027.
The company reported $105.4 million in free cash flow for the nine months ended September 30, 2026, though it noted a material weakness in internal control over financial reporting and the associated remediation risk.